Attached files
| file | filename |
|---|---|
| 8-K - 8-K - SELLAS Life Sciences Group, Inc. | gale-20141231x8xk.htm |
| EX-99.2 - EXHIBIT 99.2 - SELLAS Life Sciences Group, Inc. | gale-20141231ex992recast.htm |
| EX-23.1 - EXHIBIT 23.1 - SELLAS Life Sciences Group, Inc. | gale-20141231xex231recast.htm |
| EX-99.1 - EXHIBIT 99.1 - SELLAS Life Sciences Group, Inc. | gale-20141231xex991recast.htm |
| XML - IDEA: XBRL DOCUMENT - SELLAS Life Sciences Group, Inc. | R9999.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Galena Biopharma, Inc.
San Ramon, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-167025, 333-174076, 333-188847, 333-182505, 333-181589 and 333-188849), Form S-3MEF (No. 333-185526), and Form S-8 (No. 333-151154, 333-153847, 333-175763, 333-174819, 333-183300, 333-182578, and 333-190540) of Galena Biopharma, Inc. of our report dated March 12, 2013, relating to the consolidated financial statements, which appear in this Current Report on Form 8-K.
/s/ BDO USA, LLP
Seattle, Washington
December 4, 2015